共 11 条
[2]
Morbidity in hospitalized patients receiving human albumin:a meta-analysis of randomized,controlled trials. Vincent JL,Navickis RJ,Wilkes MM. Critical Care Medicine . 2004
[3]
C-reactive protein and al-bumin as predictors of all-cause and cardiovascular mortalityin chronic kidney disease. Menon V,Greene T,Wang X,et al. Kidney International . 2005
[4]
A comparison of albumin and saline for fluid resuscitation in the intensive care unit. Finfer S,Bellomo R,Bovce N,et al. New England Journal of Medicine, The . 2004
[5]
Debate:Albumin administration should be avoided in the critically ill. Thomas B,Pulimood,GilbertR Park,et al. CritCare . 2000
[6]
Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic haemodialysis patients. K Iseki,F Miyasato,K Tokuyama. Kidney International . 1997
[7]
Effects of a hydroxyeth-ylstarch solution on plasma colloid osmotic pressure in acutely ill pa-tients. Mbaba Mena J,De Backer D,Vincent JL. Acta Anaesthesiologica . 2000
[8]
Effects of albumin supplementation onmicrovascular permeability in septic patients. Margarson MP,Soni NC. Journal of Applied Physiology . 2002
[9]
Albumin administration:what is the evidence of clinical benefit?A systematic review of ran-domized controlled trials. Haynes GR,Navickis RJ,Wilkes MM. European Journal of Anaesthesiology . 2003
[10]
Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Cochrane Injuries Group Albumin Reviewers. British Medical Journal . 1998